Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: GMAB) | Delayed: 43.79 +3.79 (9.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.00 | 52 Week High | $ | |||
| Open | $39.84 | 52 Week Low | $ | |||
| Day High | $44.34 | P/E | N/A | |||
| Day Low | $39.64 | EPS | $ | |||
| Volume | 13,000,336 | |||||
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 115.71 -1.22 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.93 | 52 Week High | $118.49 | |||
| Open | $116.75 | 52 Week Low | $55.00 | |||
| Day High | $116.87 | P/E | N/A | |||
| Day Low | $115.12 | EPS | $-0.56 | |||
| Volume | 1,476,823 | |||||
